MBX Biosciences, Inc. — All Filings
173 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| CERT | — | 0001354457-24-000674 | Sep 12, 2024 | — |
| CORRESP | — | 0001193125-24-216604 | Sep 10, 2024 | — |
| CORRESP | — | 0001193125-24-216599 | Sep 10, 2024 | — |
| 8-A12B | 8-A12B | 0001193125-24-216643 | Sep 10, 2024 | — |
| S-1/A | S-1/A | 0001193125-24-215436 | Sep 9, 2024 | — |
| S-1/A | S-1/A | 0001193125-24-211217 | Aug 30, 2024 | — |
| UPLOAD | — | 0000000000-24-009916 | Aug 30, 2024 | — |
| CORRESP | — | 0001193125-24-211226 | Aug 30, 2024 | — |
| CORRESP | — | 0001193125-24-207272 | Aug 26, 2024 | — |
| S-1 | S-1 | 0001193125-24-206227 | Aug 23, 2024 | — |
| CORRESP | — | 0001193125-24-206234 | Aug 23, 2024 | — |
| UPLOAD | — | 0000000000-24-008281 | Jul 22, 2024 | — |
| DRS/A | — | 0000950123-24-006482 | Jul 11, 2024 | — |
| DRSLTR | — | 0000950123-24-006483 | Jul 11, 2024 | — |
| UPLOAD | — | 0000000000-24-005188 | May 7, 2024 | — |
| DRS/A | — | 0000950123-24-003577 | Apr 26, 2024 | — |
| DRSLTR | — | 0000950123-24-003578 | Apr 26, 2024 | — |
| UPLOAD | — | 0000000000-24-004189 | Apr 17, 2024 | — |
| DRS | — | 0000950123-24-002979 | Mar 22, 2024 | — |
| D | — | 0001776111-22-000001 | Nov 18, 2022 | — |
| D | — | 0001776111-20-000001 | Jul 27, 2020 | — |
| D/A | — | 0001776111-19-000002 | May 10, 2019 | — |
| D | — | 0001776111-19-000001 | May 10, 2019 | — |